Global In Vitro Fertilization (IVF) Service Market Report 2023 to 2030

Global In Vitro Fertilization (IVF) Service Market Analysis

$ 3999

The Global In Vitro Fertilization (IVF) Service Market was valued at $22,450 Mn in 2023 and is predicted to grow at a CAGR of 7.42% from 2023 to 2030, to $37,052.06 Mn by 2030. The key drivers of this industry include the prevalence of infertility, advancements in IVF technology, and growing awareness and acceptance. The industry is primarily dominated by players such as Virtus Health, CooperSurgical, IVIRMA Global, and Monash IVF Group among others.

ID: IN10GLHS011 CATEGORY: Healthcare Services GEOGRAPHY: Global AUTHOR: Aashwi Mehta

Buy Now

Global In Vitro Fertilization (IVF) Service Market Executive Summary

The Global In Vitro Fertilization (IVF) Service Market was valued at $22,450 Mn in 2023 and is predicted to grow at a CAGR of 7.42% from 2023 to 2030, to $37,052.06 Mn by 2030.

In vitro fertilization (IVF) is a widely utilized assisted reproductive technology (ART) that helps individuals and couples overcome infertility challenges. This intricate procedure combines medications and surgical techniques to enable fertilization and implantation of embryos. The IVF process includes stimulating the ovaries to produce multiple eggs, retrieving these eggs, fertilizing them with sperm in a laboratory, culturing the resulting embryos, and then transferring one or more embryos into the uterus to achieve pregnancy. IVF is recommended for various reasons, including infertility issues, advanced maternal age, genetic concerns, and for same-sex couples or single parents. While IVF can significantly increase the chances of conception, success rates depend on factors such as the woman’s age and the underlying cause of infertility, and multiple cycles may be needed.

Approximately 17.5% of adults globally, or about 1 in 6, experience infertility. The lifetime prevalence of infertility is 17.8% in high-income countries and 16.5% in low- and middle-income countries. Currently, an estimated 8-12% of women aged 20-44 worldwide face infertility that lasts for at least 12 months. The market is driven by significant factors like the prevalence of infertility, advancements in IVF technology, and growing awareness and acceptance. However, high cost of IVF procedures, variable success rates, and side effects and health risks restrict the growth and potential of the market.

Prominent players in this field include Virtus Health, CooperSurgical, IVIRMA Global, and Monash IVF Group among others.

Global In Vitro Fertilization (IVF) Service Market Report

Market Dynamics

Market Growth Drivers

Prevalence of Infertility: Around 17.5% of adults worldwide, or about 1 in 6, face infertility challenges. This widespread issue highlights a substantial need for advanced reproductive technologies, such as IVF, to assist those struggling to conceive. As more individuals and couples seek solutions to overcome infertility challenges, the demand for IVF services rises, fueling market growth.

Advancements in IVF Technology: Ongoing advancements in IVF technologies, including pre-implantation genetic testing (PGT) and embryo freezing, improve success rates and attract more patients. These innovations boost market growth by increasing treatment efficacy and expanding options for prospective parents.

Growing Awareness and Acceptance: Growing awareness and acceptance of assisted reproductive technologies (ART) among both the public and healthcare professionals promote market growth. This increased recognition helps drive demand for IVF services as more people and practitioners embrace these advanced fertility solutions.

Market Restraints

High Cost of IVF Procedures: Globally, the average cost of an IVF treatment ranges from $3,000 and $6,000/cycle depending on the facility. The high cost of IVF treatments can make them unaffordable for many individuals and couples, limiting their ability to access these services. This financial barrier can restrain overall market growth by reducing demand and adoption rates.

Variable Success Rates: With the global average IVF success rate at approximately 40% per cycle using self-eggs, variations due to age and fertility issues can lead to discouragement among patients. This variability in success rates can result in lower demand and act as a restraint on the global IVF service market.

Side Effects and Health Risks: Potential side effects and health risks linked to IVF medications among others and procedures such as stress, birth defects in children, ovarian hyperstimulation syndrome can discourage some individuals from seeking treatment. These concerns about safety and adverse effects can limit patient uptake and hinder growth in the global IVF service market.

Regional Analysis

The global IVF service market exhibits significant regional variations in infertility rates. Asia experiences the highest increase in male infertility, driving substantial demand for IVF services in the region. Conversely, Australia and Oceania show the lowest increase in male infertility, indicating a comparatively stable market. For female infertility, Asia again leads with the highest increase rate, whereas North America records the lowest increase. These disparities highlight the regional demand differences and underscore Asia's critical role in driving the global IVF service market.

Competitive Landscape

Key Players

Here are some of the major key players in the Global In Vitro Fertilisation (IVF) Service Market:

Virtus Health
CooperSurgical
IVIRMA Global
Monash IVF Group
ELITE IVF
NOW-fertility
CCRM Fertility
Indira IVF
IVI Fertility
Merck KGaA

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Global In Vitro Fertilization (IVF) Service Market Segmentation

By Cycle Type

Fresh IVF Cycles
Thawed IVF Cycles
Donor Egg/Sperm IVF Cycles

By End Users

Fertility Clinics
Hospitals
Surgical Centres
Clinical Research Institutes

By Region

North America
Latin America
Europe
Asia- Pacific
Middle East and Africa

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.